Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.
Fujimura T, Hidaka T, Kambayashi Y, Furudate S, Kakizaki A, Tono H, Tsukada A, Haga T, Hashimoto A, Morimoto R, Yamaguchi T, Takano T, Aiba S.
Fujimura T, et al. Among authors: tono h.
Oncotarget. 2017 Apr 13;8(41):71181-71187. doi: 10.18632/oncotarget.17090. eCollection 2017 Sep 19.
Oncotarget. 2017.
PMID: 29050354
Free PMC article.